Experiment 67806
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | CREAGH,T: RUCKLE,JL: TOLBERT,DT: GILTNER,J: EIZNHAMER,DA: DUTTA,B: FLAVI,MT: XU,ZO:. (2001). SAFETY AND PHARMACOKINETICS OF SINGLE DOSES OF (+)-CALANOLIDE A, A NOVEL, NATURALLY OCCURRING NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, IN HEALTHY, HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE HUMAN SUBJECTS.. 45(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | DEMONSTRATED THE SAFETY AD FAVORABLE PHARMACOKINE TIC PROFILE OF SINGLE DOSES IN HEALTHY, HIV-NEGATIVE INDIVIDUALS. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |